DiaMedica Therapeutics Statistics

Total Valuation

DMAC has a market cap or net worth of $150.21 million. The enterprise value is $107.90 million.

Market Cap	150.21M
Enterprise Value	107.90M

Important Dates

The next estimated earnings date is Wednesday, May 7, 2025, after market close.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

DMAC has 42.86 million shares outstanding. The number of shares has increased by 24.07% in one year.

Current Share Class	42.86M
Shares Outstanding	42.86M
Shares Change (YoY)	+24.07%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	38.60%
Owned by Institutions (%)	16.00%
Float	24.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.72
P/TBV Ratio	3.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.28, with a Debt / Equity ratio of 0.01.

Current Ratio	8.28
Quick Ratio	8.23
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -53.27% and return on invested capital (ROIC) is -36.05%.

Return on Equity (ROE)	-53.27%
Return on Assets (ROA)	-33.18%
Return on Invested Capital (ROIC)	-36.05%
Return on Capital Employed (ROCE)	-65.15%
Revenue Per Employee	n/a
Profits Per Employee	-$873,000
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, DMAC has paid $30,000 in taxes.

Income Tax	30,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +46.65% in the last 52 weeks. The beta is 1.49, so DMAC's price volatility has been higher than the market average.

Beta (5Y)	1.49
52-Week Price Change	+46.65%
50-Day Moving Average	5.11
200-Day Moving Average	4.63
Relative Strength Index (RSI)	32.75
Average Volume (20 Days)	95,949

Short Selling Information

The latest short interest is 366,366, so 0.85% of the outstanding shares have been sold short.

Short Interest	366,366
Short Previous Month	264,200
Short % of Shares Out	0.85%
Short % of Float	1.52%
Short Ratio (days to cover)	4.30

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-26.68M
Pretax Income	-19.85M
Net Income	-24.44M
EBITDA	-26.64M
EBIT	-26.68M
Earnings Per Share (EPS)	-$0.60

Full Income Statement

Balance Sheet

The company has $44.15 million in cash and $340,000 in debt, giving a net cash position of $43.81 million or $1.02 per share.

Cash & Cash Equivalents	44.15M
Total Debt	340,000
Net Cash	43.81M
Net Cash Per Share	$1.02
Equity (Book Value)	40.72M
Book Value Per Share	0.95
Working Capital	39.22M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$22.08 million and capital expenditures -$25,000, giving a free cash flow of -$22.10 million.

Operating Cash Flow	-22.08M
Capital Expenditures	-25,000
Free Cash Flow	-22.10M
FCF Per Share	-$0.52

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DMAC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.07%
Shareholder Yield	n/a
Earnings Yield	-16.11%
FCF Yield	-14.57%

Analyst Forecast

The average price target for DMAC is $8.00, which is 128.25% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	128.25%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 15, 2018. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Nov 15, 2018
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1